Lawrenceville, NJ, United States of America

Julie Carman

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2007-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Julie Carman

Introduction

Julie Carman is an accomplished inventor based in Lawrenceville, NJ (US). She has made significant contributions to the field of pharmacology, particularly in the area of glucocorticoid administration and rheumatoid arthritis. With a total of 4 patents to her name, her work has the potential to impact both diagnostic and therapeutic methods in medicine.

Latest Patents

One of her latest patents is titled "Method to monitor pharmacodynamic responses mediated by in vivo administration of glucocorticoids." This invention focuses on a method for monitoring pharmacodynamic responses through changes in gene signatures as pharmacodynamic markers of glucocorticoid exposure. Another notable patent is related to "Polynucleotides and polypeptides associated with the development of rheumatoid arthritis." This invention encompasses polynucleotides encoding polypeptides linked to rheumatoid arthritis, along with diagnostic and therapeutic methods for their application.

Career Highlights

Julie Carman is currently employed at Bristol-Myers Squibb Company, where she continues to innovate and contribute to advancements in medical science. Her work is characterized by a commitment to improving patient outcomes through her research and inventions.

Collaborations

Throughout her career, Julie has collaborated with esteemed colleagues, including Steven G. Nadler and Michael A. Bowen. These collaborations have further enriched her research and expanded the impact of her inventions.

Conclusion

Julie Carman's contributions to the field of pharmacology through her innovative patents demonstrate her dedication to advancing medical science. Her work not only enhances our understanding of glucocorticoids and rheumatoid arthritis but also paves the way for future research and therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…